Surveillance of antibiotic susceptibility of Enterobacteriaceae isolated from urine samples collected from community patients in a large metropolitan area, 2010-2012

Epidemiology and Infection

Volumn 142, Issue 2, 2014, Pages 399-403

  Horner, C S ^a,b   Abberley, N ^a   Denton, M ^a,b   Wilcox, M H ^a,b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antibiotic resistance; Enterobacteriaceae; surveillance; urinary tract infections (UTIs)

Indexed keywords

AMPICILLIN; CARBAPENEM; CEFEPIME; EXTENDED SPECTRUM BETA LACTAMASE; NITROFURANTOIN; TIGECYCLINE; TRIMETHOPRIM; ALKYNE; ANTIBIOTIC 07F275;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COHORT ANALYSIS; COMMUNITY CARE; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PROTEUS MIRABILIS; URINALYSIS; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; MALE; MICROBIAL SENSITIVITY TEST; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; URINE;

ALKYNES; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; URBAN POPULATION;

EID: 84894361472     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000988     Document Type: Article

References (15)

1. Foxman B. The epidemiology of urinary tract infection. Nature Reviews Urology 2010; 7: 653-660.
2. Woodford N, et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrobial Agents and Chemotherapy 2009; 53: 4472-4482.
3. Health Protection Agency. Department of Health Advisory Committee on Antimicrobial Resistance and Hospital Associated Infection (ARHAI). Advice on carbapenemase producers: recognition, infection control and treatment (http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/ CarbapenemResistance/GuidanceOnCarbapenamProducers/). Accessed 24 April 2013.
4. Woodford N, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. Journal of Antimicrobial Chemotherapy 2004; 54: 735-743.
5. Rossolini GM, D'Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum beta-lactamases. Clinical Microbiology and Infection 2008; 14 (Suppl. 1): 33-41.
6. Fernandez J, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55: 1551-1561.
7. Roux D, et al. Diversity of extended-spectrum beta-lactamase-producing Enterobacteriaceae on hospital admission. Scandinavian Journal of Infectious Diseases 2012; 44: 231-236.
8. European Centre for Disease Prevention and Control. European Antimicrobial Resistance Surveillance System (EARSS-Net) (http://www.rivm.nl/ earss/). Accessed 26 November 2012.
9. Livermore DM, et al. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. Journal of Antimicrobial Chemotherapy 2008; 62 (Suppl. 2): ii41-ii54.
10. Brabazon E, et al. Epidemiology and resistance patterns in urinary pathogens from long-term care facilities and GP populations. Irish Medical Journal 2012; 105: 177-180.
11. Farrell DJ, et al. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. Journal of Infection 2003; 46: 94-100.
12. Heginbothom M, Howe R. Antibacterial resistance and usage in Wales, 2005-2010. 2011 (http://www.wales.nhs.uk/news/21018). Accessed 13 December 2012.
13. Health Protection Agency. Management of infection guidance for primary care for consultation and local adaptation (http://www.hpa.org.uk/webc/ HPAwebFile/HPAweb-C/1194947333801). Accessed 24 April 2013.
14. Health Protection Agency. Clostridium difficile infection: how to deal with the problem (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1232006607827). Accessed 24 April 2013.
15. Hillier S, et al. When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data. Journal of Antimicrobial Chemotherapy 2006; 58: 1303-1306.